Compile Data Set for Download or QSAR

Found 812 hits with Last Name = 'rusche' and Initial = 'jr'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Histone deacetylase 6 (Homo sapiens (Human))	BDBM50005711 (CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...) Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C |r| Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase DrugBank MCE PC cid PC sid PDB UniChem	PDB US Patent	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair				3D Structure (crystal)
Histone deacetylase 1 (Homo sapiens (Human))	BDBM50005711 (CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...) Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C |r| Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase DrugBank MCE PC cid PC sid PDB UniChem	US Patent	n/a	n/a	6.70	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM50005711 (CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...) Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C |r| Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase DrugBank MCE PC cid PC sid PDB UniChem	US Patent	n/a	n/a	9.60	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 5 (Homo sapiens (Human))	BDBM50005711 (CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...) Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C |r| Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	Purchase DrugBank MCE PC cid PC sid PDB UniChem	US Patent	n/a	n/a	12.5	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 2 (Homo sapiens (Human))	BDBM50005711 (CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...) Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C |r| Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase DrugBank MCE PC cid PC sid PDB UniChem	US Patent	n/a	n/a	14.8	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207746 (US9265734, R26) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2cc(Cl)ccc2[nH]1 Show InChI InChI=1S/C21H23ClN4O2/c22-15-9-10-17-14(12-15)13-19(25-17)21(28)24-11-5-1-2-8-20(27)26-18-7-4-3-6-16(18)23/h3-4,6-7,9-10,12-13,25H,1-2,5,8,11,23H2,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207743 (US9265734, R23) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2cc(OC(F)(F)F)ccc2[nH]1 Show InChI InChI=1S/C22H23F3N4O3/c23-22(24,25)32-15-9-10-17-14(12-15)13-19(28-17)21(31)27-11-5-1-2-8-20(30)29-18-7-4-3-6-16(18)26/h3-4,6-7,9-10,12-13,28H,1-2,5,8,11,26H2,(H,27,31)(H,29,30)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM207650 (US9265734, R130) Show SMILES Nc1ccc(cc1NC(=O)CCCCCCNC(=O)c1cccnc1)-c1cccs1 Show InChI InChI=1S/C23H26N4O2S/c24-19-11-10-17(21-8-6-14-30-21)15-20(19)27-22(28)9-3-1-2-4-13-26-23(29)18-7-5-12-25-16-18/h5-8,10-12,14-16H,1-4,9,13,24H2,(H,26,29)(H,27,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	21	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Polyamine deacetylase HDAC10 (Homo sapiens (Human))	BDBM50005711 (CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...) Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C |r| Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	Purchase DrugBank MCE PC cid PC sid PDB UniChem	US Patent	n/a	n/a	22.8	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207811 (US9265734, R92) Show SMILES COc1ccc2cc([nH]c2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O3/c1-29-16-11-10-15-13-20(25-19(15)14-16)22(28)24-12-6-2-3-9-21(27)26-18-8-5-4-7-17(18)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	26	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207744 (US9265734, R24) Show SMILES Cc1ccc2[nH]c(cc2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O2/c1-15-10-11-18-16(13-15)14-20(25-18)22(28)24-12-6-2-3-9-21(27)26-19-8-5-4-7-17(19)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	27	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207742 (US9265734, R22) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2c(Cl)cccc2[nH]1 Show InChI InChI=1S/C21H23ClN4O2/c22-15-7-6-10-17-14(15)13-19(25-17)21(28)24-12-5-1-2-11-20(27)26-18-9-4-3-8-16(18)23/h3-4,6-10,13,25H,1-2,5,11-12,23H2,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	28	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207704 (BDBM207788 | US9265734, R184) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1ccc2[nH]ccc2c1 Show InChI InChI=1S/C21H24N4O2/c22-17-6-3-4-7-19(17)25-20(26)8-2-1-5-12-24-21(27)16-9-10-18-15(14-16)11-13-23-18/h3-4,6-7,9-11,13-14,23H,1-2,5,8,12,22H2,(H,24,27)(H,25,26)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207705 (US9265734, R185) Show SMILES COc1ccc2[nH]c(cc2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O3/c1-29-16-10-11-18-15(13-16)14-20(25-18)22(28)24-12-6-2-3-9-21(27)26-19-8-5-4-7-17(19)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	31	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207748 (US9265734, R28) Show SMILES Cc1cccc2cc([nH]c12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O2/c1-15-8-7-9-16-14-19(26-21(15)16)22(28)24-13-6-2-3-12-20(27)25-18-11-5-4-10-17(18)23/h4-5,7-11,14,26H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,25,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207815 (US9265734, R96) Show SMILES Cc1ccc2cc([nH]c2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O2/c1-15-10-11-16-14-20(25-19(16)13-15)22(28)24-12-6-2-3-9-21(27)26-18-8-5-4-7-17(18)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	32	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207703 (US9265734, R183) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2ccccc2[nH]1 Show InChI InChI=1S/C21H24N4O2/c22-16-9-4-6-11-18(16)25-20(26)12-2-1-7-13-23-21(27)19-14-15-8-3-5-10-17(15)24-19/h3-6,8-11,14,24H,1-2,7,12-13,22H2,(H,23,27)(H,25,26)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	33	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207789 (US9265734, R70) Show SMILES Cn1ccc2cc(ccc12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O2/c1-26-14-12-16-15-17(10-11-20(16)26)22(28)24-13-6-2-3-9-21(27)25-19-8-5-4-7-18(19)23/h4-5,7-8,10-12,14-15H,2-3,6,9,13,23H2,1H3,(H,24,28)(H,25,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	33	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207781 (US9265734, R62) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1c[nH]c2ccccc12 Show InChI InChI=1S/C21H24N4O2/c22-17-9-4-6-11-19(17)25-20(26)12-2-1-7-13-23-21(27)16-14-24-18-10-5-3-8-15(16)18/h3-6,8-11,14,24H,1-2,7,12-13,22H2,(H,23,27)(H,25,26)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	33	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 4 (Homo sapiens (Human))	BDBM50005711 (CHEBI:46024 | GNF-Pf-1011 | TRICHOSTATIN | Trichos...) Show SMILES C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C |r| Show InChI InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase DrugBank MCE PC cid PC sid PDB UniChem	US Patent	n/a	n/a	34.8	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207769 (US9265734, R49) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1c[nH]c2c(Cl)cccc12 Show InChI InChI=1S/C21H23ClN4O2/c22-16-8-6-7-14-15(13-25-20(14)16)21(28)24-12-5-1-2-11-19(27)26-18-10-4-3-9-17(18)23/h3-4,6-10,13,25H,1-2,5,11-12,23H2,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	35	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207739 (US9265734, R19) Show SMILES COc1cccc2[nH]c(cc12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O3/c1-29-20-11-7-10-17-15(20)14-19(25-17)22(28)24-13-6-2-3-12-21(27)26-18-9-5-4-8-16(18)23/h4-5,7-11,14,25H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	36	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207809 (US9265734, R90) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cccc2cc[nH]c12 Show InChI InChI=1S/C21H24N4O2/c22-17-9-3-4-10-18(17)25-19(26)11-2-1-5-13-24-21(27)16-8-6-7-15-12-14-23-20(15)16/h3-4,6-10,12,14,23H,1-2,5,11,13,22H2,(H,24,27)(H,25,26)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	36	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207817 (US9265734, R98) Show SMILES Cc1[nH]c2cc(ccc2c1C)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C23H28N4O2/c1-15-16(2)26-21-14-17(11-12-18(15)21)23(29)25-13-7-3-4-10-22(28)27-20-9-6-5-8-19(20)24/h5-6,8-9,11-12,14,26H,3-4,7,10,13,24H2,1-2H3,(H,25,29)(H,27,28)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	37	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207785 (US9265734, R66) Show SMILES COc1ccc2c(c[nH]c2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O3/c1-29-15-10-11-16-17(14-25-20(16)13-15)22(28)24-12-6-2-3-9-21(27)26-19-8-5-4-7-18(19)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	38	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207782 (US9265734, R63) Show SMILES COc1ccc2[nH]cc(C(=O)NCCCCCC(=O)Nc3ccccc3N)c2c1 Show InChI InChI=1S/C22H26N4O3/c1-29-15-10-11-19-16(13-15)17(14-25-19)22(28)24-12-6-2-3-9-21(27)26-20-8-5-4-7-18(20)23/h4-5,7-8,10-11,13-14,25H,2-3,6,9,12,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	39	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207738 (US9265734, R18) Show SMILES Cc1c([nH]c2ccccc12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O2/c1-15-16-9-4-6-11-18(16)26-21(15)22(28)24-14-8-2-3-13-20(27)25-19-12-7-5-10-17(19)23/h4-7,9-12,26H,2-3,8,13-14,23H2,1H3,(H,24,28)(H,25,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207749 (US9265734, R29) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2cccc(F)c2[nH]1 Show InChI InChI=1S/C21H23FN4O2/c22-15-8-6-7-14-13-18(26-20(14)15)21(28)24-12-5-1-2-11-19(27)25-17-10-4-3-9-16(17)23/h3-4,6-10,13,26H,1-2,5,11-12,23H2,(H,24,28)(H,25,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	41	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207820 (US9265734, R101) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1ccc2cc[nH]c2c1 Show InChI InChI=1S/C21H24N4O2/c22-17-6-3-4-7-18(17)25-20(26)8-2-1-5-12-24-21(27)16-10-9-15-11-13-23-19(15)14-16/h3-4,6-7,9-11,13-14,23H,1-2,5,8,12,22H2,(H,24,27)(H,25,26)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	41	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM207751 (US9265734, R31) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2c(OC(F)F)cccc2[nH]1 Show InChI InChI=1S/C22H24F2N4O3/c23-22(24)31-19-10-6-9-16-14(19)13-18(27-16)21(30)26-12-5-1-2-11-20(29)28-17-8-4-3-7-15(17)25/h3-4,6-10,13,22,27H,1-2,5,11-12,25H2,(H,26,30)(H,28,29)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	41	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207768 (US9265734, R48) Show SMILES Cc1[nH]c2ccc(cc2c1C)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C23H28N4O2/c1-15-16(2)26-20-12-11-17(14-18(15)20)23(29)25-13-7-3-4-10-22(28)27-21-9-6-5-8-19(21)24/h5-6,8-9,11-12,14,26H,3-4,7,10,13,24H2,1-2H3,(H,25,29)(H,27,28)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	41	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207818 (US9265734, R99) Show SMILES Cc1ccc2[nH]nc(C(=O)NCCCCCC(=O)Nc3ccccc3N)c2c1 Show InChI InChI=1S/C21H25N5O2/c1-14-10-11-17-15(13-14)20(26-25-17)21(28)23-12-6-2-3-9-19(27)24-18-8-5-4-7-16(18)22/h4-5,7-8,10-11,13H,2-3,6,9,12,22H2,1H3,(H,23,28)(H,24,27)(H,25,26)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	45	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207760 (US9265734, R40) Show SMILES COc1cccc2c(c[nH]c12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O3/c1-29-19-11-7-8-15-16(14-25-21(15)19)22(28)24-13-6-2-3-12-20(27)26-18-10-5-4-9-17(18)23/h4-5,7-11,14,25H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	46	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207762 (US9265734, R42) Show SMILES Cc1[nH]c2c(cccc2c1C)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C23H28N4O2/c1-15-16(2)26-22-17(15)9-8-10-18(22)23(29)25-14-7-3-4-13-21(28)27-20-12-6-5-11-19(20)24/h5-6,8-12,26H,3-4,7,13-14,24H2,1-2H3,(H,25,29)(H,27,28)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	47	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207819 (US9265734, R100) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1c[nH]c2ccc(Cl)cc12 Show InChI InChI=1S/C21H23ClN4O2/c22-14-9-10-18-15(12-14)16(13-25-18)21(28)24-11-5-1-2-8-20(27)26-19-7-4-3-6-17(19)23/h3-4,6-7,9-10,12-13,25H,1-2,5,8,11,23H2,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	48	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207766 (US9265734, R46) Show SMILES CCOc1ccc2[nH]c(cc2c1)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C23H28N4O3/c1-2-30-17-11-12-19-16(14-17)15-21(26-19)23(29)25-13-7-3-4-10-22(28)27-20-9-6-5-8-18(20)24/h5-6,8-9,11-12,14-15,26H,2-4,7,10,13,24H2,1H3,(H,25,29)(H,27,28)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	49	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207751 (US9265734, R31) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2c(OC(F)F)cccc2[nH]1 Show InChI InChI=1S/C22H24F2N4O3/c23-22(24)31-19-10-6-9-16-14(19)13-18(27-16)21(30)26-12-5-1-2-11-20(29)28-17-8-4-3-7-15(17)25/h3-4,6-10,13,22,27H,1-2,5,11-12,25H2,(H,26,30)(H,28,29)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	52	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207790 (US9265734, R71) Show SMILES Cn1nc(C(=O)NCCCCCC(=O)Nc2ccccc2N)c2ccccc12 Show InChI InChI=1S/C21H25N5O2/c1-26-18-12-7-4-9-15(18)20(25-26)21(28)23-14-8-2-3-13-19(27)24-17-11-6-5-10-16(17)22/h4-7,9-12H,2-3,8,13-14,22H2,1H3,(H,23,28)(H,24,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	54	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207747 (US9265734, R27) Show SMILES COc1cccc2cc([nH]c12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O3/c1-29-19-11-7-8-15-14-18(26-21(15)19)22(28)24-13-6-2-3-12-20(27)25-17-10-5-4-9-16(17)23/h4-5,7-11,14,26H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,25,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207765 (US9265734, R45) Show SMILES Cn1cc(C(=O)NCCCCCC(=O)Nc2ccccc2N)c2ccccc12 Show InChI InChI=1S/C22H26N4O2/c1-26-15-17(16-9-4-7-12-20(16)26)22(28)24-14-8-2-3-13-21(27)25-19-11-6-5-10-18(19)23/h4-7,9-12,15H,2-3,8,13-14,23H2,1H3,(H,24,28)(H,25,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	56	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207745 (US9265734, R25) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2cc(F)ccc2[nH]1 Show InChI InChI=1S/C21H23FN4O2/c22-15-9-10-17-14(12-15)13-19(25-17)21(28)24-11-5-1-2-8-20(27)26-18-7-4-3-6-16(18)23/h3-4,6-7,9-10,12-13,25H,1-2,5,8,11,23H2,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	57	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207704 (BDBM207788 | US9265734, R184) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1ccc2[nH]ccc2c1 Show InChI InChI=1S/C21H24N4O2/c22-17-6-3-4-7-19(17)25-20(26)8-2-1-5-12-24-21(27)16-9-10-18-15(14-16)11-13-23-18/h3-4,6-7,9-11,13-14,23H,1-2,5,8,12,22H2,(H,24,27)(H,25,26)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	57	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207755 (US9265734, R35) Show SMILES Cn1c(cc2cc(Cl)ccc12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H25ClN4O2/c1-27-19-11-10-16(23)13-15(19)14-20(27)22(29)25-12-6-2-3-9-21(28)26-18-8-5-4-7-17(18)24/h4-5,7-8,10-11,13-14H,2-3,6,9,12,24H2,1H3,(H,25,29)(H,26,28)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	58	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207771 (US9265734, R52) Show SMILES Cc1cccc(c1)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C20H25N3O2/c1-15-8-7-9-16(14-15)20(25)22-13-6-2-3-12-19(24)23-18-11-5-4-10-17(18)21/h4-5,7-11,14H,2-3,6,12-13,21H2,1H3,(H,22,25)(H,23,24)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	58	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207808 (US9265734, R89) Show SMILES COc1cccc2[nH]cc(C(=O)NCCCCCC(=O)Nc3ccccc3N)c12 Show InChI InChI=1S/C22H26N4O3/c1-29-19-11-7-10-18-21(19)15(14-25-18)22(28)24-13-6-2-3-12-20(27)26-17-9-5-4-8-16(17)23/h4-5,7-11,14,25H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	58	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM207748 (US9265734, R28) Show SMILES Cc1cccc2cc([nH]c12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H26N4O2/c1-15-8-7-9-16-14-19(26-21(15)16)22(28)24-13-6-2-3-12-20(27)25-18-11-5-4-10-17(18)23/h4-5,7-11,14,26H,2-3,6,12-13,23H2,1H3,(H,24,28)(H,25,27)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	59	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207741 (US9265734, R21) Show SMILES Nc1ccccc1NC(=O)CCCCCNC(=O)c1cc2c(F)cccc2[nH]1 Show InChI InChI=1S/C21H23FN4O2/c22-15-7-6-10-17-14(15)13-19(25-17)21(28)24-12-5-1-2-11-20(27)26-18-9-4-3-8-16(18)23/h3-4,6-10,13,25H,1-2,5,11-12,23H2,(H,24,28)(H,26,27)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	60	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM207755 (US9265734, R35) Show SMILES Cn1c(cc2cc(Cl)ccc12)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C22H25ClN4O2/c1-27-19-11-10-16(23)13-15(19)14-20(27)22(29)25-12-6-2-3-9-21(28)26-18-8-5-4-7-17(18)24/h4-5,7-8,10-11,13-14H,2-3,6,9,12,24H2,1H3,(H,25,29)(H,26,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	61	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 3 (Homo sapiens (Human))	BDBM207776 (US9265734, R57) Show SMILES CN1CCN(CC1)c1cccc(c1)C(=O)NCCCCCC(=O)Nc1ccccc1N Show InChI InChI=1S/C24H33N5O2/c1-28-14-16-29(17-15-28)20-9-7-8-19(18-20)24(31)26-13-6-2-3-12-23(30)27-22-11-5-4-10-21(22)25/h4-5,7-11,18H,2-3,6,12-17,25H2,1H3,(H,26,31)(H,27,30)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	66	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair
Histone deacetylase 1 (Homo sapiens (Human))	BDBM207649 (US9265734, R129) Show SMILES Nc1ccc(cc1NC(=O)CCCCCCNC(=O)c1cccnc1)-c1ccccc1 Show InChI InChI=1S/C25H28N4O2/c26-22-14-13-20(19-9-4-3-5-10-19)17-23(22)29-24(30)12-6-1-2-7-16-28-25(31)21-11-8-15-27-18-21/h3-5,8-11,13-15,17-18H,1-2,6-7,12,16,26H2,(H,28,31)(H,29,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	66	n/a	n/a	n/a	n/a	n/a	n/a
BIOMARIN PHARMACEUTICAL INC. US Patent					Assay Description HDAC enzyme inhibition assays were performed using purified HDACs 1-10 essentially as described in Beckers et al., 2007, Int. J. Cancer., 121:1138-48...				US Patent US9265734 (2016) BindingDB Entry DOI: 10.7270/Q2BK1B5B
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 812 total )  |  Next  |  Last  >>

Jump to: